245 related articles for article (PubMed ID: 25070092)
1. Susceptibility and diversity in the therapy-refractory genus scedosporium.
Lackner M; Hagen F; Meis JF; Gerrits van den Ende AH; Vu D; Robert V; Fritz J; Moussa TA; de Hoog GS
Antimicrob Agents Chemother; 2014 Oct; 58(10):5877-85. PubMed ID: 25070092
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of Pseudallescheria boydii and Scedosporium apiospermum to new antifungal agents.
Zeng J; Kamei K; Zheng Y; Nishimura K
Nihon Ishinkin Gakkai Zasshi; 2004; 45(2):101-4. PubMed ID: 15118667
[TBL] [Abstract][Full Text] [Related]
3. Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species.
Lackner M; de Hoog GS; Verweij PE; Najafzadeh MJ; Curfs-Breuker I; Klaassen CH; Meis JF
Antimicrob Agents Chemother; 2012 May; 56(5):2635-42. PubMed ID: 22290955
[TBL] [Abstract][Full Text] [Related]
4. Molecular identification and susceptibility of clinically relevant Scedosporium spp. in China.
Wang H; Wan Z; Li R; Lu Q; Yu J
Biomed Res Int; 2015; 2015():109656. PubMed ID: 26550562
[TBL] [Abstract][Full Text] [Related]
5. The 'species complex' issue in clinically relevant fungi: A case study in Scedosporium apiospermum.
Chen M; Zeng J; De Hoog GS; Stielow B; Gerrits Van Den Ende AH; Liao W; Lackner M
Fungal Biol; 2016 Feb; 120(2):137-46. PubMed ID: 26781369
[TBL] [Abstract][Full Text] [Related]
6. Re-identification of clinical isolates of the Pseudallescheria boydii-complex involved in near-drowning.
Tintelnot K; Wagner N; Seibold M; de Hoog GS; Horré R
Mycoses; 2008 Sep; 51 Suppl 3():11-6. PubMed ID: 18782237
[TBL] [Abstract][Full Text] [Related]
7. Molecular phylogeny of the Pseudallescheria boydii species complex: proposal of two new species.
Gilgado F; Cano J; Gené J; Guarro J
J Clin Microbiol; 2005 Oct; 43(10):4930-42. PubMed ID: 16207945
[TBL] [Abstract][Full Text] [Related]
8. Molecular variability of Pseudallescheria boydii, a neurotropic opportunist.
Rainer J; de Hoog GS; Wedde M; Gräser Y; Gilges S
J Clin Microbiol; 2000 Sep; 38(9):3267-73. PubMed ID: 10970369
[TBL] [Abstract][Full Text] [Related]
9. Genotypic diversity and antifungal susceptibility of Scedosporium species from clinical settings in China.
Chen M; Zhu X; Cong Y; Chen H; Hou Q; Hong N; Chen X; Lei W; Cai J; Lu X; Shuai L; Li X; Deng S; Xu J; Liao W; Pan W; Xu H; de Hoog S
Mycoses; 2022 Dec; 65(12):1159-1169. PubMed ID: 35899426
[TBL] [Abstract][Full Text] [Related]
10. Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.
Gilgado F; Serena C; Cano J; Gené J; Guarro J
Antimicrob Agents Chemother; 2006 Dec; 50(12):4211-3. PubMed ID: 17015631
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and susceptibility testing of new species of pseudallescheria and scedosporium in a collection of clinical mold isolates.
Alastruey-Izquierdo A; Cuenca-Estrella M; Monzón A; Rodriguez-Tudela JL
Antimicrob Agents Chemother; 2007 Feb; 51(2):748-51. PubMed ID: 17101671
[TBL] [Abstract][Full Text] [Related]
12. Clinical manifestations and susceptibility of Scedosporium/Lomentospora infections at a tertiary medical centre in Taiwan from 2014 to 2021: A retrospective cohort study.
Lao CK; Ou JH; Fan YC; Wu TS; Sun PL
Mycoses; 2023 Oct; 66(10):923-935. PubMed ID: 37449538
[TBL] [Abstract][Full Text] [Related]
13. Molecular identification tools for sibling species of Scedosporium and Pseudallescheria.
Lackner M; Klaassen CH; Meis JF; van den Ende AH; de Hoog GS
Med Mycol; 2012 Jul; 50(5):497-508. PubMed ID: 22004363
[TBL] [Abstract][Full Text] [Related]
14. Intraspecific diversity of species of the Pseudallescheria boydii complex.
Zeng JS; Fukushima K; Takizawa K; Zheng YC; Nishimura K; Gräser Y; De Hoog GS
Med Mycol; 2007 Sep; 45(6):547-58. PubMed ID: 17710625
[TBL] [Abstract][Full Text] [Related]
15. Antifungal triazoles and polymorphonuclear leukocytes synergize to cause increased hyphal damage to Scedosporium prolificans and Scedosporium apiospermum.
Gil-Lamaignere C; Roilides E; Mosquera J; Maloukou A; Walsh TJ
Antimicrob Agents Chemother; 2002 Jul; 46(7):2234-7. PubMed ID: 12069979
[TBL] [Abstract][Full Text] [Related]
16. Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum.
Cuenca-Estrella M; Ruiz-Díez B; Martínez-Suárez JV; Monzón A; Rodríguez-Tudela JL
J Antimicrob Chemother; 1999 Jan; 43(1):149-51. PubMed ID: 10381115
[TBL] [Abstract][Full Text] [Related]
17. Distribution of the different species of the Pseudallescheria boydii/Scedosporium apiospermum complex in French patients with cystic fibrosis.
Zouhair R; Rougeron A; Razafimandimby B; Kobi A; Bouchara JP; Giraud S
Med Mycol; 2013 Aug; 51(6):603-13. PubMed ID: 23461512
[TBL] [Abstract][Full Text] [Related]
18. Discrimination of Scedosporium prolificans against Pseudallescheria boydii and Scedosporium apiospermum by semiautomated repetitive sequence-based PCR.
Steinmann J; Schmidt D; Buer J; Rath PM
Med Mycol; 2011 Jul; 49(5):475-83. PubMed ID: 21108573
[TBL] [Abstract][Full Text] [Related]
19. Molecular identification and in vitro antifungal susceptibility of Scedosporium complex isolates from high-human-activity sites in Mexico.
Elizondo-Zertuche M; de J Treviño-Rangel R; Robledo-Leal E; Luna-Rodríguez CE; Martínez-Fierro ML; Rodríguez-Sánchez IP; González GM
Mycologia; 2017; 109(6):874-881. PubMed ID: 29494271
[TBL] [Abstract][Full Text] [Related]
20. Infection and colonisation due to Scedosporium in Northern Spain. An in vitro antifungal susceptibility and molecular epidemiology study of 60 isolates.
Lackner M; Rezusta A; Villuendas MC; Palacian MP; Meis JF; Klaassen CH
Mycoses; 2011 Oct; 54 Suppl 3():12-21. PubMed ID: 21995658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
